Stay updated on Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial page.
Latest updates to the Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial page
- Check4 days agoChange DetectedThe clinical trial record is displayed, including the study design, eligibility criteria, treatment arms, outcome measures, participating locations, and published results. The record also provides study documents and links to the participating institutions.SummaryDifference55%
- Check11 days agoChange DetectedThe footer shows a newer ClinicalTrials.gov site revision, while the study record remains inaccessible behind a 403 error.SummaryDifference0.2%
- Check18 days agoChange DetectedA site-wide NIH banner announces a transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) under Executive Order 14434.SummaryDifference1%
- Check25 days agoChange DetectedThe footer’s displayed ClinicalTrials.gov revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%
- Check32 days agoChange DetectedThe site footer now identifies the release as v3.7.1 instead of v3.7.0.SummaryDifference0.2%
- Check53 days agoChange DetectedAn error page (403 Forbidden) is now displayed, replacing the previous content. The page shows a minimal header and a 403 message, indicating access is blocked and most study-related sections are no longer visible.SummaryDifference19%
Stay in the know with updates to Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab vs Ipilimumab Plus Nivolumab Clinical Trial page.